MRNX

Defiance Daily Target 2X Long MRNA ETF

183.82

Oct 09 • 3:59 PM ET +39.81 (27.64%)

184.25

Aftermarket • 7:59 PM ET +0.43 (0.23%)

Financial Exchange Traded Fund USA NYSE

Category	Equity - Leveraged / Inverse
Sponsor	Defiance ETFs
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	1.34%
Inverse/Leveraged
IPO	Feb 04, 2026

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	Yes / Yes

Tags	U.S.
Tags	single-asset
Tags	MRNA
Tags	leverage
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	42.84%
SMA50	107.81%
SMA200	304.28%

Return% 1Y	-
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	7.97%
Flows% 3M	55.28%
Flows% YTD	60.97%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	9
AUM	55.14M
NAV/sh
52W High	167.89 9.49%
52W Low	14.95 1129.57%
Volatility	20.02% 15.71%
ATR (14)	19.84
RSI (14)	70.06
Beta	-
Rel Volume	1.77
Avg Volume	285.35K
Volume	505,424

Perf Week	35.41%
Perf Month	148.94%
Perf Quarter	389.53%
Perf Half Y	599.20%
Perf YTD	791.90%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	144.01
Price	183.82
Change %	27.64%

Feb-09-26 04:08PM

Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X

(Benzinga)

Defiance Daily Target 2X Long MRNA ETF is an actively managed, single-stock leveraged exchange-traded fund designed to provide 200% of the daily share price performance of Moderna, Inc. (MRNA). The fund is intended for sophisticated investors and active traders who seek to express tactical bullish views on mRNA-based biotechnology innovation through amplified daily exposure.

open in yahoo | open in marketwatch | open in google

MRNX

Defiance Daily Target 2X Long MRNA ETF

Upgrade your Finviz experience